Magnus Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-2,890
Closed -$256K – 247
2021
Q1
$256K Buy
+2,890
New +$287K 0.06% 190

Other funds holding ARKG

Magnus Financial Group's ARKG Position: Q2 2021 in Review

Magnus Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 2,890 shares — an estimated $256K sold.

Magnus Financial Group first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $256K in Q1 2021. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Magnus Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Magnus Financial Group sold 2,890 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $256K.
  • Magnus Financial Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Magnus Financial Group's ARK Genomic Revolution ETF position peaked at $256K in Q1 2021.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Magnus Financial Group's 13F filing for Q2 2021, filed 6 Aug 2021.